- Home
- CLRO vs MYNZ Comparison
CLRO vs MYNZ Comparison
Compare CLRO & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- MYNZ
- Stock Information
- Founded
- CLRO 1983
- MYNZ 2021
- Country
- CLRO United States
- MYNZ Germany
- Employees
- CLRO N/A
- MYNZ N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- MYNZ Health Care
- Exchange
- CLRO Nasdaq
- MYNZ Nasdaq
- Market Cap
- CLRO 7.5M
- MYNZ 7.9M
- IPO Year
- CLRO N/A
- MYNZ 2021
- Fundamental
- Price
- CLRO $4.17
- MYNZ $1.75
- Analyst Decision
- CLRO
- MYNZ Buy
- Analyst Count
- CLRO 0
- MYNZ 2
- Target Price
- CLRO N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- CLRO 18.2K
- MYNZ 172.6K
- Earning Date
- CLRO 08-14-2025
- MYNZ 03-31-2025
- Dividend Yield
- CLRO N/A
- MYNZ N/A
- EPS Growth
- CLRO N/A
- MYNZ N/A
- EPS
- CLRO N/A
- MYNZ N/A
- Revenue
- CLRO $9,689,000.00
- MYNZ $893,991.00
- Revenue This Year
- CLRO N/A
- MYNZ $26.06
- Revenue Next Year
- CLRO N/A
- MYNZ $4.97
- P/E Ratio
- CLRO N/A
- MYNZ N/A
- Revenue Growth
- CLRO N/A
- MYNZ N/A
- 52 Week Low
- CLRO $3.83
- MYNZ $1.30
- 52 Week High
- CLRO $21.00
- MYNZ $18.40
- Technical
- Relative Strength Index (RSI)
- CLRO 34.90
- MYNZ 52.10
- Support Level
- CLRO $3.83
- MYNZ $1.70
- Resistance Level
- CLRO $4.68
- MYNZ $1.90
- Average True Range (ATR)
- CLRO 0.27
- MYNZ 0.12
- MACD
- CLRO 0.07
- MYNZ 0.03
- Stochastic Oscillator
- CLRO 31.48
- MYNZ 69.39
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.